Mama, Amera A.
HRN: 28-75-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/05/2026
04/12/2026
IV
2.25g
Q6
CAP MR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: